Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001576885-25-000051
Filing Date
2025-03-27
Accepted
2025-03-27 16:38:20
Documents
5
Effectiveness Date
2025-03-27
Reference 429
333-278267

Document Format Files

Seq Description Document Type Size
1 S-8 acumenpharma-sx82025.htm S-8 61625
2 EX-FILING FEES exhibit107s-82025.htm EX-FILING FEES 22666
3 EX-5.1 exhibit51s-82025.htm EX-5.1 7370
4 EX-23.2 exhibit232eys-8consent.htm EX-23.2 2106
5 GRAPHIC image_0.jpg GRAPHIC 3169
  Complete submission text file 0001576885-25-000051.txt   99415
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Filer) CIK: 0001576885 (see all company filings)

EIN.: 364108129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-286176 | Film No.: 25780015
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)